Business Wire

METI will hold GGX x TCFD Summit

27.9.2023 15:35:00 EEST | Business Wire | Press release

Share

From 10:00 on October 2 (Mon.), the Ministry of Economy, Trade and Industry (METI) will hold the Global Green Transformation (GGX) Conference and the TCFD Summit, which until now have attracted participation from a wide range of sectors including global industry, finance, governments, regulators, and international organizations, will be held jointly. In order to further develop discussions on transition finance, avoided emissions, industry decarbonization, and other topics related to how business and finance contribute to decarbonization, the event will promote mutual cooperation between the government, business, and financial sectors, and hold discussions to lead the international rule-making process to achieve both emission reductions and economic growth.

  • Outline of Global Green Transformation (GGX) Conference and the TCFD Summit

Date: October 2nd, 2023 10:00-17:00 (JST)
Organizer: Ministry of Economy, Trade and Industry (METI)
Co-organizer: TCFD Consortium, The World Business Council for Sustainable Development (WBCSD)
Format: Hybrid (On-Site and On-Line)
Web Site: https://tcfd-summit.go.jp/indexEn.html

  • Online Registration

Online Registration Site: https://jcs.eventsair.com/ggxtcfd2023/attendeereg/Site/Register
*Registration deadline: Oct 1st (Sun.) (JST, GMT+9:00)

  • Program
  • Opening Remarks
    HATAKEYAMA Yojiro (Director-General, Industrial Science, Technology and Environment Policy Bureau, Ministry of Economy, Trade and Industry)
    TOKURA Masakazu (Chairman, Keidanren (Japan Business Federation))
    KATO Masahiko (Chairperson, Japanese Bankers Association)
    David Atkin (CEO, Principles for Responsible Investment (PRI))
  • Keynote Speech 1
    Gianluigi Benedetti (Ambassador, Embassy of Italy in Tokyo)
  • Panel Discussion 1 “Towards Net-Zero Society ~Industrial Decarbonisation~”
    What efforts are needed towards creating a "Green Market" to accelerate industrial decarbonization, focusing on the creation of demand?
    [Moderator]
    Peter Bakker (President and CEO, World Business Council for Sustainable Development (WBCSD))
    [Panelist]
    Nancy Gillis (Program Head, First Movers Coalition, World Economic Forum)
    Rana Ghoneim (Chief, Energy Systems and Industrial Decarbonization Unit, United Nations Industrial Development Organization)
    TEZUKA Hiroyuki (Fellow, Executive, JFE Steel Corporation)
    MITA Noriyuki (Vice President, Sustainability Department, Mitsubishi Chemical Group Corporation *After October 1st)
    KOBAYASHI Izuru (Deputy Director-General for Environmental Affairs, Ministry of Economy, Trade and Industry)
  • Panel Discussion 2 “Solution Provider and Avoided Emissions”
    Companies are increasingly expected to provide solutions to social challenges. What is the potential of the idea of "avoided emissions" to evaluate a company's contribution to decarbonization of the society as a whole by providing solutions?
    [Moderator]
    HAYASHI Reiko (Director and Deputy President, BofA Securities Japan Co., Ltd.)
    [Panelist]
    Jason Mortimer (Head of Sustainable Investment - Fixed Income, Investment Department - Global Solutions, Nomura Asset Management)
    UEHARA Hirotoshi (Executive Officer, Quality & Environment, CS, Panasonic Operational Excellence Co., Ltd.)
    HIRUTA Takako (Country Leader, CS&Q, Schneider Electric Japan, Inc)
  • Keynote Speech 3
    Emmanuel Faber (Chair, ISSB)
    MIYAZONO Masataka (President, Government Pension Investment Fund)
    MIZUNO Hiromichi (Founder And CEO, Good Steward Partners, LLC)
  • Panel Discussion 3 “Future of Climate-Related Financial Disclosures”
    As climate-related financial disclosures rapidly expand, what efforts are needed going forward? How can disclosure promote transition finance?
    [Moderator]
    NAGAMURA Masaaki (Fellow, International Initiatives, Tokio Marine Holdings, Inc.)
    [Panelist]
    Alex Michie (Head of Secretariat, GFANZ)
    IKEDA Satoshi (Chief Sustainable Finance Officer, Strategy Development And Management Bureau, Financial Services Agency)
    ISHIKAWA Tomohiro (Chief Regulatory Engagement Officer, Corporate Planning Division, Mitsubishi UFJ Financial Group (MUFG))
    KITAGAWA Keiko (General Manager, Sustainability Promotion Unit, Global Investor Relations Group, Finance Strategy and Planning Division, JERA Co., Inc.)
  • Keynote Speech 4
    Mary Schapiro (Head, The TCFD Secretariat)
    ITO Kunio (Chair, The TCFD Consortium)
  • Panel Discussion 4 “Further Promotion of Transition Finance”
    As the understanding of the importance of transition finance grows globally, what efforts are needed to further promote investments toward decarbonization of corporates and the private financing towards them?
    [Moderator]
    KIHARA Shinichi (Director General for International Policy on Carbon Neutrality, Ministry of Economy, Trade and Industry)
    [Panelist]
    Nicholas Pfaff (Deputy Chief Executive, Head of Sustainable Finance, International Capital Market Association)
    Sean Kidney (CEO, Climate Bonds Initiative)
    Eila Kreivi (Director, Chief Sustainable Finance Advisor, Secretariat General, European Investment Bank)
    KUBOTA Nobuhiko (Managing Executive Officer, General Manager of Technology & Intelligence Integration, IHI Corporation)
  • Closing Remarks
    Peter Bakker (President and CEO, World Business Council for Sustainable Development (WBCSD))

*The above programs and speakers may be subject to change at the discretion of the organizer.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Contact information for inquiries
GGX x TCFD Summit 2023 Registration Desk
E-mail: ggxtcfd2023-reg@convention.co.jp

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 11:00:00 EEST | Press release

OM Pharma will reveal preliminary results from the REACH study at the European Academy of Allergy and Clinical Immunology (EAACI) Congress. REACH is the first and largest multi-country real-world evidence (RWE) study to date evaluating the impact of Broncho-Vaxom® in patients with recurrent respiratory tract infections (RTIs).1,2 The findings offer critical new clinical evidence of the therapy's effectiveness in everyday clinical practice. In a real-world cohort of 15,794 paediatric (aged >1 year), adolescent, adult and elderly patients in China, Italy, and Belgium, Broncho-Vaxom® was associated with reductions in RTI recurrence and healthcare utilisation at 12 and 24 months after treatment initiation, compared with the 12 months prior to starting the therapy.1 “The REACH real-world evidence study shows that Broncho-Vaxom® can significantly reduce infections requiring medical visits across age groups and co-morbidities,” said Anna Thomas, Chief Scientific Officer at OM Pharma. “Recurre

Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 18:15:00 EEST | Press release

Incyte (Nasdaq:INCY) today announced updated clinical data from two Phase 1 studies evaluating the safety, tolerability and efficacy of INCA033989, a first-in-class mutant calreticulin (mutCALR)-targeted monoclonal antibody, in patients with mutCALR-expressing myeloproliferative neoplasms (MPNs). INCA033989 demonstrated rapid, clinically meaningful responses and consistent molecular activity across both myelofibrosis (MF) and essential thrombocythemia (ET), with convergent evidence supporting the potential for disease modification. These findings are being presented in oral and poster presentations at the European Hematology Association (EHA) 2026 Congress in Stockholm, Sweden (Session: Myeloproliferative neoplasms – Clinical, Presentation numbers: S216, PS1983, PF884). “The data presented at EHA 2026 demonstrate clinically meaningful and consistent responses with INCA033989 across both myelofibrosis and essential thrombocythemia,” said Pablo J. Cagnoni, M.D., President of Incyte and G

Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 13:00:00 EEST | Press release

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP, the current standard of care, as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. These data are being highlighted in a prestigious Plenary Abstracts Session at the European Hematology Association (EHA) 2026 Congress, being held June 11 - 14, 2026, in Stockholm, Sweden (Abstract # S101. Plenary Abstract Session. June 13, 6:00 - 7:30 a.m. ET [12:00-1:30 p.m. CEST]). frontMIND results were als

Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202613.6.2026 00:31:00 EEST | Press release

Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til

IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 19:36:00 EEST | Press release

IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, strategy, and business transformation. She most recently served as Global Head of Deloitte Digital and previously held senior global leadership roles,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye